Journal article · 2010
Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies
Regenerative Medicine, 5(4), 569–579 · Published 1 July 2010 · DOI 10.2217/rme.10.55
In brief
“Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies” is a 2010 journal article by Melissa K. Carpenter and Larry A. Couture, published in Regenerative Medicine. OpenAlex counts 32 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 32
- Most cited in
- 2014 (6)
- Field-weighted impact
- 1.13
- References
- 50
- Authors
- 2
Abstract
Induced pluripotent stem (iPS) cells offer tremendous opportunity for the creation of autologous cellular therapies, in which gene correction or the avoidance of immune response issues are desirable. In addition, iPS cells avoid the ethical concerns raised by the sourcing of human embryonic stem cells (hESCs) from embryos. iPS cells share many characteristics with hESCs… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Carpenter, M. K., & Couture, L. A. (2010). Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies. Regenerative Medicine, 5(4), 569–579. https://doi.org/10.2217/rme.10.55
MLA 9
Carpenter, Melissa K., and Larry A. Couture. “Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies.” Regenerative Medicine, vol. 5, no. 4, 2010, pp. 569–579. https://doi.org/10.2217/rme.10.55.
Chicago
Carpenter, Melissa K. and Larry A. Couture. 2010. “Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies.” Regenerative Medicine 5 (4): 569–579. https://doi.org/10.2217/rme.10.55.
Harvard
Carpenter, M. K. and Couture, L. A. (2010) ‘Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies’, Regenerative Medicine, 5(4), pp. 569–579. doi:10.2217/rme.10.55.
IEEE
M. K. Carpenter and L. A. Couture, “Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies,” Regenerative Medicine, vol. 5, no. 4, pp. 569–579, 2010, doi: 10.2217/rme.10.55.
BibTeX
@article{carpenter2010regulatory,
title = {{Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies}},
author = {Carpenter, Melissa K. and Couture, Larry A.},
journal = {Regenerative Medicine},
year = {2010},
volume = {5},
number = {4},
pages = {569--579},
doi = {10.2217/rme.10.55},
url = {https://doi.org/10.2217/rme.10.55}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2012 | 2 | |
| 2013 | 1 | |
| 2014 | 6 | |
| 2015 | 3 | |
| 2016 | 2 | |
| 2017 | 2 | |
| 2018 | 2 | |
| 2019 | 2 | |
| 2020 | 1 | |
| 2025 | 2 |
Its field-weighted citation impact is 1.13: it has been cited 1.13 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- induced pluripotent stem cells
- autologous cell therapy
- regulatory challenges
- reproducibility
- safety testing
- clinical translation
- human embryonic stem cells
- gene correction
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Carpenter, M. K., & Couture, L. A. (2010). Regulatory Considerations for the Development of Autologous Induced Pluripotent Stem Cell Therapies. Regenerative Medicine, 5(4), 569–579. https://doi.org/10.2217/rme.10.55
How many times has this paper been cited?
32 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Melissa K. Carpenter, Larry A. Couture.
What is the DOI of this paper?
10.2217/rme.10.55, permanently at https://doi.org/10.2217/rme.10.55. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.